Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.

Ministry of Health Flags Off Critical Human Immunodeficiency Virus (HIV) Commodities at Mission for Essential Drugs and Supplies (MEDS) ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

MSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

Ibalizumab continues to demonstrate long-term efficacy and safety as part of combination antiretroviral therapy in heavily ...

A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...